Holen Sie sich die Stockscreener-App
6.7833
61.89%
2.5933
Finanzdaten der Bolt Biotherapeutics Inc-Aktie (BOLT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
80.77%
0.005
|
0.026 | 2.50 | 2.169 | 1.804 |
| Operating Expenses |
9.86%
8.379
|
7.627 | 9.585 | 9.872 | 11.01 |
| Operating Income/Loss |
10.17%
-8.374
|
-7.601 | -7.085 | -7.703 | -9.21 |
| Nonoperating Income/Loss |
83.19%
0.654
|
0.357 | 0.454 | 0.559 | 0.649 |
| Net Income/Loss |
6.57%
-7.72
|
-7.244 | -6.631 | -7.144 | -8.561 |
| Basic Average Shares |
0.60%
1.6905
|
1.6804 | - | 1.9194 | 1.9176 |
| Diluted Average Shares |
0.60%
1.6905
|
1.6804 | - | 1.9194 | 1.9176 |
| Basic Earnings Per Share |
6.03%
-4.57
|
-4.31 | - | -3.72 | -4.46 |
| Diluted Earnings Per Share |
6.03%
-4.57
|
-4.31 | - | -3.72 | -4.46 |
0.62%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):